Industry focus

Forecasting and preparing for generic competition

PCR-Online-Indistry-Focus-White-paperThe Healthcare and Science business of Thomson Reuters earlier released the white paper, The Five Myths of Generic Competition, highlighting what originator pharmaceutical and biotech companies can do to improve their forecasting of the likely timing, source and intensity of competition from generic drugs.

A call for innovative solutions

The Innovation_Hub_hosts_Skincare_New_Product_Development_Challenge_for_black_African_skins_productThe Innovation Hub is inviting industry players to respond to the Skincare New Product Development Challenge by submitting a single product that provides a unique solution resulting in even-toned, smooth facial skin for black African skins.

A 26 per cent rise in Pfizer’s oncology business

 

PfizerSpeciality Pfizer Inc. reported financial results for the third quarter of 2013, with a revenue decrease of two per cent or US$310 million. The company sees the results as solid, especially in the face of product losses of exclusivity.

Changes coming after morning-after pill found ineffective in women over 80kgs

 

Norlevo is_distributed_in_Europe_and_some_African_and_South_American_countriesIn November European health authorities approved an MRP variation to Norlevo, an emergency contraceptive or ‘morning-after’ pill with levonorgestrel as active ingredient. The approval may result in product labelling changes.

Dettol / Lysol franchise growth puts Reckitt Benckiser revenue on the up

The Dettol_Lysol_franchise_helped_drive_Reckitt_Benckisers_YTD_Hygiene_net_revenue_increaseAccording to Reckitt Benckiser’s (RB) Interim Management Statement for the third quarter of 2013, the company’s focus on Health and Hygiene and emerging markets, along with its move to drive growth in Europe and North American region, through increased investment, is delivering good results.

Would you like to receive our FREE e-newsletter?

* indicates required
Close